A Study to Analyze Weight Gain in Post-Kidney Transplant Subjects

Overview

About this study

The main purpose of this study is to investigate pre-transplant risk factors and beliefs regarding weight gain in patients with a diagnosis of type 2 diabetes mellitus (T2DM) who have undergone a kidney transplant. The aim is to guide an understanding of the rationale behind weight gain and an exploration of potential preventative measures, ultimately resulting in recommendations for future patient-centered interventions at a Midwestern tertiary healthcare center. The research question follows the PICOT format: population, intervention, comparison, outcome, and time. The question of interest is: In adult patients ≥ 18 years of age with T2DM who received a kidney transplant (P), that have gained >5% body weight (I) compared to those who have not (C) what is the impact of pre-transplant risk factors and T2DM disease burden, psychological, and physiological factors on weight gain (O) 1 year after transplant (T)?

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Male or female, 18 years of age or older.
Recent transplantation (< 1 year).
Diagnosis of type 2 diabetes pre-transplant.
Recipient of a first time, solitary kidney transplant between August 1, 2020 and January 1, 2021.

Exclusion Criteria:

Individuals < 18 years of age.
Prior transplants and/or combined organ transplant.
Type 1 diabetes.
No documented follow-up.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Jennifer Hill, APRN, C.N.P., D.N.P.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Aleksandra Kukla M.D. (507) 284-8712 Kukla.Aleksandra@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Jennifer Hill, APRN, C.N.P., D.N.P.	Closed for enrollment	Contact information: Jennifer Hill APRN, C.N.P., D.N.P. Hill.Jennifer2@mayo.edu
Rochester, Minn. Mayo Clinic principal investigator Jennifer Hill, APRN, C.N.P., D.N.P.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Jennifer Hill APRN, C.N.P., D.N.P. Hill.Jennifer2@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Jennifer Hill, APRN, C.N.P., D.N.P.

Closed-enrolling by invitation

Contact information:

Aleksandra Kukla M.D.

(507) 284-8712

Kukla.Aleksandra@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Jennifer Hill, APRN, C.N.P., D.N.P.

Closed for enrollment

Contact information:

Jennifer Hill APRN, C.N.P., D.N.P.

Hill.Jennifer2@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Jennifer Hill, APRN, C.N.P., D.N.P.

Closed-enrolling by invitation

Contact information:

Jennifer Hill APRN, C.N.P., D.N.P.

Hill.Jennifer2@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials